Literature DB >> 18167113

Evaluation of prognostic factors in the surgical treatment of adrenal gland tumors in dogs: 41 cases (1999-2005).

Pamela Schwartz1, Janet R Kovak, Alexandra Koprowski, Lori L Ludwig, Sebastien Monette, Philip J Bergman.   

Abstract

OBJECTIVE: To identify preoperative predictors of survival and assess intraoperative and postoperative complications and survival rates for dogs undergoing adrenalectomy.
DESIGN: Retrospective case series. ANIMALS: 41 dogs that underwent adrenalectomy. PROCEDURES: Records were reviewed to collect data regarding preoperative variables. Intraoperative and postoperative variables were also recorded. Variables were evaluated for association with survival duration via log-rank analysis for categoric variables and by use of Cox proportional hazards. Median survival times were calculated by use of Kaplan-Meier life table analysis.
RESULTS: 9 (22.0%) dogs did not survive to discharge. Intraoperative mortality rate was 4.8%. Overall Kaplan-Meier median survival time was 690 days. Variables significantly associated with shorter survival times included preoperative weakness or lethargy, thrombocytopenia, increased BUN concentration, increased partial thromboplastin time (PTT), increased aspartate transaminase (AST) activity, hypokalemia, intraoperative hemorrhage, and concurrent nephrectomy. Postoperative variables significantly associated with shorter survival times included pancreatitis and renal failure. In multivariate analysis, preoperative hypokalemia, preoperative increased BUN concentration, and concurrent nephrectomy were significantly associated with a shorter survival time. CONCLUSIONS AND CLINICAL RELEVANCE: A high mortality rate was associated with adrenalectomy in dogs; however, those that survived until discharge from a hospital had long survival times. Preoperative factors associated with a shorter survival time were weakness or lethargy, thrombocytopenia, increased BUN concentration, increased PTT, increased AST activity, and hypokalemia. Studies are needed to evaluate how treatment for these factors may affect or change outcome after adrenalectomy. Dogs with adrenal masses that require concurrent nephrectomy and cause intraoperative hemorrhage have a guarded prognosis.

Entities:  

Mesh:

Year:  2008        PMID: 18167113     DOI: 10.2460/javma.232.1.77

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  12 in total

1.  The Utrecht Score: A novel histopathological scoring system to assess the prognosis of dogs with cortisol-secreting adrenocortical tumours.

Authors:  Karin Sanders; Koen Cirkel; Guy C M Grinwis; Erik Teske; Sebastiaan A van Nimwegen; Jan A Mol; Jan Willem Hesselink; Hans S Kooistra; Sara Galac
Journal:  Vet Comp Oncol       Date:  2019-04-07       Impact factor: 2.613

2.  C-kit, flt-3, PDGFR-β, and VEGFR2 expression in canine adrenal tumors and correlation with outcome following adrenalectomy.

Authors:  Kayla Harding; Carlos H De Mello Souza; Keijiro Shiomitsu; Elizabeth Maxwell; Judit Bertran
Journal:  Can J Vet Res       Date:  2021-10       Impact factor: 1.310

3.  Insulin-like growth factor--phosphatidylinositol 3 kinase signaling in canine cortisol-secreting adrenocortical tumors.

Authors:  M M J Kool; S Galac; N van der Helm; S Corradini; H S Kooistra; J A Mol
Journal:  J Vet Intern Med       Date:  2015-01       Impact factor: 3.333

4.  Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014-2017).

Authors:  Margaret L Musser; Kathryn L Taikowski; Chad M Johannes; Philip J Bergman
Journal:  BMC Vet Res       Date:  2018-09-03       Impact factor: 2.741

5.  Molecular markers of prognosis in canine cortisol-secreting adrenocortical tumours.

Authors:  Karin Sanders; Gerjanne J van Staalduinen; Maarten C M Uijens; Jan A Mol; Erik Teske; Adri Slob; Jan Willem Hesselink; Hans S Kooistra; Sara Galac
Journal:  Vet Comp Oncol       Date:  2019-08-04       Impact factor: 2.613

6.  Histopathological changes in the pancreas due to decreased pancreatic blood flow in a canine tachycardia-induced cardiomyopathy model.

Authors:  Aritada Yoshimura; Takahiro Ohmori; Kokoro Itou; Ryo Ishi; Yuri Matsumura; Yuhei Wada; Miori Kishimoto; Tomoko Iwanaga; Naoki Miura; Kazuhiko Suzuki; Ryuji Fukushima
Journal:  J Vet Med Sci       Date:  2021-03-15       Impact factor: 1.267

7.  Long-term survival of dogs with adrenal-dependent hyperadrenocorticism: a comparison between mitotane and twice daily trilostane treatment.

Authors:  C Arenas; C Melián; M D Pérez-Alenza
Journal:  J Vet Intern Med       Date:  2014-02-03       Impact factor: 3.333

8.  Electrolyte Disturbances Are Associated with Non-Survival in Dogs-A Multivariable Analysis.

Authors:  Robert Goggs; Sage De Rosa; Daniel J Fletcher
Journal:  Front Vet Sci       Date:  2017-08-18

9.  Repetitive ultrasonographic assessment of adrenal size and shape changes: a clue for an asymptomatic sex hormone-secreting adenoma.

Authors:  Seunghyeon Yoon; Heejin Oui; Ju-Hwan Lee; Kyu-Yeol Son; Kyoung-Oh Cho; Jihye Choi
Journal:  J Vet Sci       Date:  2017-03-30       Impact factor: 1.672

10.  Safety of percutaneous ultrasound-guided fine-needle aspiration of adrenal lesions in dogs: Perception of the procedure by radiologists and presentation of 50 cases.

Authors:  Pascaline Pey; Alessia Diana; Federica Rossi; Jeremy Mortier; Ulrike Kafka; Stefanie Veraa; Anna Groth; Megan MacLellan; Chiara Marin; Federico Fracassi
Journal:  J Vet Intern Med       Date:  2020-03-11       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.